Long-term safety of intravenous ibandronic acid for up to 4 years in metastatic breast cancer: an open-label trial (Q44603186)

From Wikidata
Jump to navigation Jump to search
scientific article published in January 2006
edit
Language Label Description Also known as
English
Long-term safety of intravenous ibandronic acid for up to 4 years in metastatic breast cancer: an open-label trial
scientific article published in January 2006

    Statements

    Long-term safety of intravenous ibandronic acid for up to 4 years in metastatic breast cancer: an open-label trial (English)
    Martin Pecherstorfer
    Saul Rivkin
    Jean-Jacques Body
    Ingo Diel
    Bengt Bergström
    1 January 2006
    315-322

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit